TB-500 is a polypeptide that has been determined to be built from of 43 amino acids. It is sometimes classified as ThymosinBeta 4, which itself is occasionally abbreviated as Tβ4. It is available for purchase of the expressed, exclusive use of scientific study and research on animal test subjects. The peptide is administered to the animal test subject via subcutaneous injection. It contains a molecular weight of 4963.44.
One of TB-500’s chief functions is its capability to control actin; the cell building protein that is essential to a cell’s genetic design and overall functionality. Actin is a vital part of several cellular processes, including cytokenesis, cell signaling, cell motility, vesicle and organelle movement, cell division, muscle contraction, and the establishment and maintenance of cell shape and cell junctions. Scientific research conducted on animal test subjects has determined that the peptide’s structural integrity enables it to bind to actin protein, which in turn creates a sequestering molecule within eukaryotic cells that block acting polymerization (that is, the process of reacting monomer molecules along with a chemical reaction to form polymer chains or three dimensional networks). Scientific study based on animal test subjects has also determined that the peptide promotes cytoskeleton cell migration as it engages with the actin found in the cells. Specifically, it causes an accelerated form of endothelial and keratinocyte migration. The first form of migration aids in the formation and maintenance of blood vessels, and the second form of migration acts to form a epidermal barrier against various environmental damages such as heat, water loss, pathogens, and UV radiation. Additionally, studies on animal test subjects determine that TB-500 promotes the formation and growth of blood vessels, which enables cell migration to happen in a more efficient basis. Furthermore, these studies have determined that TB-500 is present in wound fluid and does in fact contain natural wound healing properties. Scientific studies based on animal test subjects have also determined that the peptide’s low molecular weight gives it the ability to travel through the tissues over the course of long distances. It has not yet been determined through scientific studies on animal test subjects if TB-500 is anabolic in its nature. However, it does produce results that are consistent with results produced by peptides that are known to be anabolic.
Theoretical Benefits of TB-500
Scientific study on animal test subjects relating to TB-500 has determined that the peptide contains a host of theoretical benefits. Some of these benefits include:
- Accelerated wound repair – Because TB-500 promotes an elevated rate of natural wound healing and anti-inflammatory factors, it allows for wounds that would otherwise heal slowly recover at a much faster rate.
- Accelerated injury recovery – Because of TB-500’s facility to promote a quicker rate of cellular generation, scientific study based on animal test subjects have determined that the peptide has the capability allow skeletal and muscular tissue to recover from various injuries at quicker rate.
- Enhanced rate of flexibility – Scientific study on animal test subjects has determined that the anti-inflammatory properties that TB-500 possesses enable tissues to endure a wider range of stretching without experiencing damage or fatigue. This wider range allows the animal test subject to be able to take on a higher amount of movement and physical stress without experiencing any hyperextension.
- Increased muscular tissue – Scientific research performed on animal test subjects have determined that TB-500’s enhanced capabilities concerning cellular migration allow for cellular growth and transport to happen at an accelerated process. This then allows for a more efficient rate of skeletal and muscular tissue growth amongst the test subjects.
In addition, scientific research conducted on animal test subjects have determined other theoretical benefits regarding the peptide including cell differentiation in blood vessels, collage deposition, cell, and angiogenesis (that is, the growth of new blood cells from earlier blood vessels) in dermal tissues. It should also be noted that scientific research based on animal test subjects have not yielded any substantial negative side effects in relation to TB-500.
For Scientific Use Only
Even though scientific study has been conducted on animal test subjects in order to determine TB-500’s range of mechanics, functionality, and theoretical benefits, it should be noted that the derived findings associated with the peptide are still based in current laboratory research. Because TB-500 is currently in the research phase, any matters of purchase relating to this peptide must exclusively be contained to scientific research, and all study should be contained to the restrictions of a strictly controlled environment such as a medical research facility or a laboratory.